Neuroscientific Biopharmaceuticals Ltd Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Unknown, was filed 02 Jun 2026.
Neuroscientific Biopharmaceuticals Ltd: what insiders have been doing
Neuroscientific Biopharmaceuticals Ltd is a listed company. Its directors and officers file their transactions with ASX. 3 insiders have disclosed 3 filings since 18 October 2025.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 senior executive.
The clock since the last published purchase (2 June 2026) now reads 160 days.
Compared with its exchange (1,605 companies, median 4 filings), a count of 3 filings is below the norm. Looking back to 2026, when coverage begins, insiders filed 1 purchase and no sales.
Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- Unknown-33.0%Entry A$0.09 · Close 16 Oct 2026 A$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Executives0ASX
- ShareASXISIN AU0000012973ASX:2924-03096921-6A1328214
- ▲Unknown0ASXShareASXISIN AU0000012973ASX:2924-03096445-6A1328016Canonical exit: 30 Aug 2026 (T+90)
3 of 3 declarations
About Neuroscientific Biopharmaceuticals Ltd
Neuroscientific Biopharmaceuticals Ltd is a company focused on developing treatments for neurological disorders. It is listed on the XASX market.